Bankmed Changes 2015

Effective 1 January 2015 the following changes will apply on Bankmed:

1. The Human Papilloema Virus (HPV) Vaccine will be covered at 100% of the Scheme’s medicine reference price, limited to a

total course of three doses (administered four months apart) per female beneficiary between the ages of 9 to 16.

2. Oral contraceptive benefits limit will increase to R1500 per beneficiary per annum. Once the patients limit is reached a

message will be returned to the provider that the claim will be funded from the member’s day to day benefits.

3. The following Authorised Chronic Appliances can be obtained on the acute option without additional motivation or scheme

approval, to the value indicated below:

Blood Pressure Monitor R920

Nebuliser R1295

Glucometer R650

4. Ondansetron containing products will be funded from the acute benefit at a maximum quantity of 15 tablets a month up to 45 tablets in 365 days. Rejection RMR 136 (Chronic preauth required by Scheme) will be returned once the patients limit has been reached.



About Medinol:
Medinol is one of the few purpose-built practice management application to meet the unique needs of independent private healthcare providers. Today Medinol helps over 130 providers throughout South Africa run more efficient and profitable practices, while delivering outstanding patient care. As an on-premise software, Medinol and the data it manages, is fully under your control. This enhances your independence and privacy: what happens in your rooms, stays in your rooms. Medinol helps manage your patient information, generates your billings, submits your claims, control your outstandings, and get your accounts paid quickly. Medinol has been in operation since 1984 demonstrating its proven efficacy. Medinol’s mission is to help independent practices succeed in an ever-changing healthcare environment. More information can be found at


medical billing software


Fudley Bezuidenhout Pr.Eng.
Founder and CEO
Ph: 021-906-2296
Cell: 082-688-9610